| Financial Year |
March 31 2023 |
| Monetary Funds |
226,119,998.47 |
| Held-for-trading Financial Assets |
140,216,638.90 |
| Notes Receivable |
86,750,079.61 |
| Accounts Receivable |
551,646,682.97 |
| Advances to Suppliers |
33,715,093.32 |
| Other Receivables |
17,572,151.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
493,152,016.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
318,137.85 |
| Other Current Assets |
20,105,837.05 |
| Total Current Assets |
1,690,962,575.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
38,215.29 |
| Long-term Equity Investment |
40,223,573.22 |
| Investment Properties |
-- |
| Fixed Assetes |
524,049,109.09 |
| Under-construction Projects |
11,819,616.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
63,034,987.32 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
23,851,827.76 |
| Deferred Income Tax Assets |
79,482,691.76 |
| Other Non-Current Assets |
26,816,186.88 |
| Sub-Total of Non-Current Assets |
852,315,986.55 |
| Total Assets |
2,543,278,562.31 |
| Short-Term Loans |
633,669,805.72 |
| Trading Financial liabilities |
-- |
| Notes Payable |
263,888,193.92 |
| Accounts Payable |
240,465,042.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
27,483,151.30 |
| Taxes Payable |
7,551,678.78 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,809,827.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
49,771,911.10 |
| Other Current Liabilities |
19,392,772.30 |
| Sub-Total of Current Liabilities |
1,324,942,114.52 |
| Long-term Loans |
99,272,272.50 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
13,645,381.17 |
| Special Payable |
-- |
| Estimatied Liabilities |
6,217,648.25 |
| Deferred Income Tax Liabilities |
5,266,050.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
188,661,282.19 |
| Total Liabilities |
1,513,603,396.71 |
| Paid-In Capital(Or Share Stock) |
147,783,896.00 |
| Capital Surplus |
614,668,859.36 |
| Surplus Reserve |
32,611,317.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
231,568,961.16 |
| Minority Stockholder's Interest |
3,024,912.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,026,650,253.60 |
| Owner's Equity（Stockholder's Equity） |
1,029,675,165.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,543,278,562.31 |
